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 Summary 
The research reported in this paper on the changes in absorbance and the calibration 
of a proposed UVA (320-400 nm) dosimeter have established the phenothiazine/mylar 
combination as a potential UVA dosimeter for population studies of UVA exposures. 
The change in optical absorbance at 370 nm was employed to quantify the UVA 
exposures. This change starts to saturate at approximately 0.3. This relates to solar 
UVA exposures at a sub-tropical site on a horizontal plane of approximately three to 
four hours. The shape of this calibration curve varies with the season. This can be 
overcome in the same manner as for polysulphone where the dosimeter is calibrated 
for the conditions that it will be employed to measure the UVA exposures. 
Introduction 
Dosimeters based on polysulphone1 for measuring the UV wavelengths shorter than 
330 nm have been widely employed. These have been calibrated for the measurement 
of the erythemal UV exposures.2 Polysulphone dosimeters have been employed in the 
measurement of UV exposures during normal daily activities to different population 
groups.3-8  
 
The damaging effects and premature photoageing of human skin due to cumulative 
exposures to the longer UVA wavelengths (320 – 400 nm) have been reported.9,10 A 
predominance of UVA mutations in the basal cell layer of human skin have been 
reported,11 implicating UVA as a potential carcinogen in human skin. The longer 
wavelengths of the UVA also penetrate to a greater depth in human skin.12
 
For solar UV, the UVA irradiances are higher than the UVB irradiances by 
approximately a factor of 100.13 Additionally, the ratio of the UVA to the erythemal 
UV irradiances is lower for smaller solar zenith angles (SZA) and higher for the larger 
SZA. The ratio of UVA to UVB is significantly increased when the solar UV is 
filtered through untinted glass for environments such as behind glass in an office or 
greenhouse and in a car with the windows wound up.14-18  
 
The prevalence of the UVA and the potential damaging influences of the UVA 
wavelengths require research on the UVA exposures to various population groups in 
different environments. These population exposure studies will require a convenient, 
easy to process and unobtrusive dosimeter that is responsive to only the UVA 
wavelengths. Several dosimeters responsive to the UVA have been proposed.19-22 
However, these require more processing or analysis compared to the simplicity of use 
of polysulphone. This paper will present the properties and characteristics of a 
dosimeter that is responsive to the UVA wavelengths and that is simple to use and 
analyse so that it can be employed in large scale population UVA exposure studies.  
Materials and methods 
Dosimeter production 
A dosimeter sensitive to the UVA wavelengths was developed for this project. This 
was based on the chemical phenothiazine cast in thin film form.23 A dosimeter based 
on this chemical is sensitive to both the UVA and the UVB waveband. In order to 
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produce a dosimeter that responds to the UVA wavelengths only, it was filtered with a 
second thin film that transmits predominantly the UVA and does not transmit the 
UVB.24 The filter material employed for this purpose was mylar film with a thickness 
of approximately 0.13 mm (Cadillac Plastics, Australia).  
 
The optical transmission of the mylar was measured in a UV spectrophotometer 
(model 1601, Shimadzu Co., Kyoto, Japan) from 280 to 400 nm in 1 nm increments 
and three scans of the transmission undertaken with the mylar placed normal to the 
spectrophotometer beam. For these spectrophotometric measurements and subsequent 
ones presented in this research, the post-exposure measurements have all been 
undertaken immediately post-exposure of the sample in order to ensure consistency. 
The previous use of mylar for UVB exclusion in plant effects research has shown that 
mylar deteriorates and the UVA transmission decreases over a period of 
approximately a week due to UV radiation.25 The UVA dosimeter is intended to be 
employed to measure the UVA exposures for periods of less than one day. Over this 
period, the amount of deterioration of the mylar is expected to be significantly less. In 
order to investigate if there is any significant change in the transmission of the mylar, 
the spectral transmission was measured pre-exposure and post-exposure to solar UV 
on 6 May 2005 for periods of 2 h, 3 h and 7 h.  
 
The phenothiazine undergoes a change in optical absorbance (ΔA) as a result of 
exposure to UV radiation.23 The influence of solar UV on the phenothiazine was 
investigated by measuring the spectral transmission from 280 to 400 nm in 1 nm 
increments for the un-exposed phenothiazine and measuring the transmission again 
after exposure of the dosimeter on a horizontal plane for 75 min. The UVA dosimeter 
was fabricated by mounting the phenothiazine in thin film form in a 3 cm x 3 cm 
holder constructed from PVC sheeting with a thickness of several mm. This holder 
has an opening of approximately 1.2 cm x 1.6 cm (Figure 1). The thickness of the film 
was uniform and of the order of 20 μm. The mylar was then mounted over the 
phenothiazine with adhesive labels so that no UV reached the phenothiazine without 
first passing through the mylar. 
 
The change in optical absorbance of the UVA dosimeter was investigated by 
measuring firstly the pre-exposure absorbance from 280 to 400 nm in the 
spectrophotometer. The dosimeters were exposed to 20 min, 60 min and 90 min of 
solar UV on 17 January and the post exposure optical absorbance measured. The 
effect of the visible radiation on the dosimeter was estimated by employing a UG11 
(Solar Light Co., PA, USA) filter over a dosimeter to act as a broadband UVA filter. 
The pre- and post-exposure absorbances at 370 nm were measured for two UVA 
dosimeters.  Both dosimeters were exposed simultaneously to 30 minutes of solar 
radiation, one with the UG11 filter over the opening of the filter and one without. 
Calibration 
The calibration of the dosimeters was undertaken by exposing a series of dosimeters 
to differing exposures on a horizontal plane while concurrently measuring the 
exposures with a UVA meter (model 501, Solar Light Co., PA, USA) that is 
permanently installed on an unshaded roof (Figure 1) of a building at the University 
of Southern Queensland, Toowoomba, Australia (27.6 oS, 151.9 oE). This calibration 
relates the UVA exposures to the changes in optical absorbance. The UVA meter is 
temperature stabilised to 25 oC and it records the horizontal plane UVA exposures 
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every five minutes. It is calibrated twice a year to a spectroradiometer mounted on the 
same unshaded roof and measuring the solar UV spectrum in 0.5 nm increments for 
every 5 minutes. This spectroradiometer is housed in an environmentally sealed 
container with temperature stabilisation and it has calibration traceable to the National 
Physical Laboratory, UK standard.26 A calibration of the spectroradiometer is 
undertaken every six months and a stability check of the instrument is undertaken 
regularly. 
 
The UVA dosimeters were calibrated for a low solar zenith angle (SZA) range in 
summer on 21 January between 7.55 am and 11.55 am with a SZA range of 57o to 8o 
respectively. Additionally, they were calibrated for a high SZA range on 6 May 
between 9.25 am and 2.35 pm with the maximum and minimum SZA in this interval 
of 56o and 44o respectively. Dosimeters were exposed for intervals of 5, 10, 15, 20, 
30, 45, 60, 90, 120, 180, 210 and 310 min. For each of these dosimeters the 
absorbance was measured pre-exposure and immediately post-exposure at 370 nm for 
4 sites over the dosimeter. The four sites were obtained by rotating each dosimeter by 
ninety degrees between each measurement about an axis parallel to the 
spectrophotometer beam. 
 
Results 
Dosimeter 
The spectral transmission of the mylar before exposure to solar UV and after exposure 
for periods of 2 h, 3 h and 7 h are provided in Figure 2. The transmission of the filter 
drops quickly to zero for wavelengths shorter than 320 nm. The small slope in the 
transmission for wavelengths longer than 320 nm is taken into account in the 
calibration of the dosimeter. For the 2 h exposure there is no difference between the 
pre- and post-exposure transmission. There are minor differences for the 3 h and 7 h 
exposures, however at 400 nm, these are less than 3%. The presented transmission 
data is the average at each wavelength of four spectral scans of the mylar. The 
standard deviation at each wavelength of these scans is of the same order of 
magnitude as these differences.  
 
The spectral transmission of the phenothiazine pre- and post-exposure to solar UV is 
provided in Figure 3. The largest change in optical transmission occurs at two 
wavebands, namely in the UVB and the UVA. The fabricated UVA dosimeter is 
shown in Figure 1 next to the UVA meter. The mylar filter that is employed is 
lightweight and unobtrusive and would not interfere with the versatility of the 
dosimeter. The spectral absorbances of the combined phenothiazine/mylar dosimeter 
to produce the UVA dosimeter measured pre-exposure and post-exposure to 20 min, 
60 min and 90 min of solar UV on 17 January are provided in Figure 4. This data 
shows that the largest ΔA occurs at a wavelength of approximately 370 nm or longer. 
Consequently, 370 nm has been selected for the determination of the calibration of the 
UVA dosimeter and for the use as a dosimeter. 
 
The ΔA at 370 nm for the dosimeters that were exposed with and without the 
broadband UVA filter were within 6.5% of each other. Consequently, the effect of the 
visible waveband on the ΔA measured at 370 nm is considered to be within the error 
associated with measuring the UVA radiation with the dosimeter. 
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Calibration 
The calibration graphs for the low SZA and high SZA cases are provided in Figure 5. 
The data points are the averages of the four ΔA’s measured for each dosimeter and the 
error bars on the x-axis values are the standard deviation of the four measurements. 
An exponential expression has been fitted to the calibration data for the low SZA case 
of the form: 
 
AeUVA Δ= 66.1699.14   kJ/m2 
 
with an R2 value for this expression of 0.99 and where UVA is the UVA exposures in 
units of kJ/m2. For the high SZA, the calibration expression has the form: 
 
  J/mAeUVA Δ= 61.1704.9  k 2 
 
with an R2 value for this expression of 0.98.  
 
Discussion 
Population studies of the UVA exposures to humans during normal daily activities 
have not yet been widely undertaken. The research reported in this paper on the 
changes in absorbance and the calibration of a proposed UVA dosimeter have 
established the phenothiazine/mylar combination as a potential UVA dosimeter for 
population studies of UVA exposures. The size and lightweight properties of the 
dosimeter means that it can be attached to different anatomical sites to measure the 
UVA exposures to those sites. The change in the optical transmission of the mylar 
filter due to UV exposures up to seven hours is minimal and if there are any changes 
they will be incorporated in the calibration of the dosimeter. 
 
The usage of the dosimeter requires the calibration against a calibrated UVA meter. 
The shape of this calibration curve varies with the season. This can be overcome in 
the same manner as for polysulphone where the dosimeter is calibrated for the 
conditions that it will be employed to measure the UVA exposures. The change in 
optical absorbance at 370 nm of the dosimeter starts to saturate at approximately 0.3. 
This relates to solar UVA exposures at a sub-tropical site on a horizontal plane of 
approximately three to four hours. For the case of filtered UV through building 
window glass or car window glass, the period of exposure before the response begins 
to saturate may be different. This will be investigated further in future research. 
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Figure Captions 
 
Figure 1 – The UVA dosimeter next to the UVA meter employed for the calibration 
of the dosimeters.
 
Figure 2 – The spectral transmission of the mylar before exposure to solar UV and 
after exposure to periods of (a) 2 h, (b) 3 h and (c) 7 h (The before and after exposure 
curves are overlapping for the 2 h and 3 h exposures).
 
Figure 3 – The optical transmission of the phenothiazine before and after exposure to 
75 minutes of solar UV on a horizontal plane.
 
Figure 4 – Spectral absorbance of the UVA dosimeter measured pre-exposure and 
post-exposure to 20 min, 60 min and 90 min (from bottom to top curve) of solar UV 
on 17 January.
 
Figure 5 – (a) Low SZA calibration for the UVA dosimeter and (b) a high SZA 
calibration.
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Figure 1 – The UVA dosimeter next to the UVA meter employed for the calibration 
of the dosimeters. 
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Figure 2 – The spectral transmission of the mylar before exposure to solar UV and 
after exposure to periods of (a) 2 h, (b) 3 h and (c) 7 h (The before and after exposure 
curves are overlapping for the 2 h and 3 h exposures). 
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Figure 3 – The optical transmission of the phenothiazine before and after exposure to 75 minutes of 
solar UV on a horizontal plane. 
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Figure 4 – Spectral absorbance of the UVA dosimeter measured pre-exposure and 
post-exposure to 20 min, 60 min and 90 min (from bottom to top curve) of solar UV 
on 17 January.  
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Figure 5 – (a) Low SZA calibration for the UVA dosimeter and (b) a high SZA 
calibration. 
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